您的位置: 首页 > 农业专利 > 详情页

FORMES POSOLOGIQUES À LIBÉRATION IMMÉDIATE D'OXYBATE DE SODIUM
专利权人:
Jazz Pharmaceuticals; Inc.
发明人:
申请号:
EP09825191.1
公开号:
EP2341910B1
申请日:
2009.10.20
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
The present invention provides a pharmaceutical composition, presented as a solid unit dosage form adapted for oral administration of sodium oxybate. The preferred unit dosage form is a tablet comprising a relatively high weight-percentage of sodium oxybate, in combination with a relatively small weight-percentage of total excipients. This permits the tablets to contain/deliver a pharmaceutically effective amount, e.g., about 0.5-1.5 g of sodium oxybate in each tablet with a delivery profile similar to that of the liquid form. The tablets are bioequivalent to the liquid form.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充